The toxin resembled glucagon, a hormone that raises blood sugar, so, scientists named it glucagon-like-peptide 1, or GLP-1. In the early 2000s, we got our first medical breakthrough with GLP-1, a drug called exenatide (Byetta) approved for the treatment of type 2 diabetes
According to a clinical trial, individuals using semaglutide at higher doses (1.7 mg and 2.4 mg) experienced 6.9% weight loss after 3 months
How the Program Works Medical consultation (telehealth or in-office) Comprehensive eligibility review and health assessment Prescription issued only after clinical approval Personalized dosing plan with gradual titration Ongoing follow-ups and progress monitoring Treatment is physician-guided to ensure safety, appropriate dosing, and long-term success
The single biggest mistake
It may also slow gastric emptying thereby improving satiety
It has been approved for weight management under the brand name Wegovy